-
×
DAPAFON M EXTRA
1 × ₹1,850.00 -
×
DUBOSE 25
1 × ₹949.00
-
×
ASORIN MV2
1 × ₹1,499.00
Subtotal: ₹4,298.00
Glimepiride+ Metformin + Voglibose Tablets
Showing all 2 results
Filter
Category
- Anti Ulcer / Antacids / Anti Helmenthics / PPI /Gastric / Antiemetic
- Anti-Diabetic
- Anti-Malarial
- Anti-Thyroid
- Antibiotics and Antibacterials
- Anticold – Cough / Histamanics / Pyretics /Analgesics / Muscle Relaxants / Ortho
- Best Selling Products
- Cardiology
- Commercial Product Range
- Cosmetics
- Cream
- Cream, Gel & Ointments
- Dental
- Dermatology
- Dusting Powder
- Dusting Powder, Soaps & Lotions
- Ear/Eye/Nasal
- Gel & Ointments
- Gynaecology/Women's Care/Infertility
- Husk
- Husk, Proteins & Sachets
- Immunity Boosters
- Infusions
- Injectables
- Liquids
- Liver Protectors
- Near Expiry Products
- Nephrology/Urology
- Neurology – Psychiatric
- Paediatric
- Proteins & Sachets
- Recent Launched Products
- Respules and Inhalation
- Soaps & Lotions
- Soft Gelatin Capsules
- Uncategorized
Price
Color
Size
Brand
Fawn Incor Private Limited
Fawn Incor Private Limited is one of the fastest-growing and rapidly developing PCD Pharma Franchise Company in India and Third-Party Manufacturing companies in India. With proven expertise in the healthcare sector, we cater to the diverse needs of our customers by offering a wide range of general and specialty divisions, including Gynecology, Dermatology, Orthopedics, Neurology, Ophthalmology, Cardiac-Diabetic care, and PPIs.
USEFUL LINKS
Contact us
Panchkula (Admin Office)
Plot No 404, Basement, Industrial Area, Phase I, Panchkula (HR) 134113
Mumbai(Corporate Office)
3rd Floor, Tree House, Raghuvanshi Mills, Lower Parel (West), Mumbai – 400013 India
Netherlands (Overseas)
Fawn Inc. 217, Lichstraat, Eindhoven, Netherlands
+91-9888099264
+91 6280 986 280
+91-7814201203
info@fawnincor.com
Fawnincor@gmail.com
My Cart
-
×
DAPAFON M EXTRA
1 × ₹1,850.00
-
×
DUBOSE 25
1 × ₹949.00
-
×
ASORIN MV2
1 × ₹1,499.00
Subtotal: ₹4,298.00
Copyright © Fawn Incor Pvt. Ltd. 2024. All Rights Reserved.
